Published in Genes Dev on August 01, 2012
The roles of K(+) channels in cancer. Nat Rev Cancer (2013) 1.46
Potassium channels in cell cycle and cell proliferation. Philos Trans R Soc Lond B Biol Sci (2014) 1.29
Targeting potassium channels in cancer. J Cell Biol (2014) 1.15
EAG2 potassium channel with evolutionarily conserved function as a brain tumor target. Nat Neurosci (2015) 0.95
hERG channel function: beyond long QT. Acta Pharmacol Sin (2013) 0.90
Optical volume and mass measurements show that mammalian cells swell during mitosis. J Cell Biol (2015) 0.90
Voltage-gated ion channels in cancer cell proliferation. Cancers (Basel) (2015) 0.89
K(+) channels and cell cycle progression in tumor cells. Front Physiol (2013) 0.87
The sigma-1 receptor: a regulator of cancer cell electrical plasticity? Front Physiol (2013) 0.84
Molecular basis of potassium channels in pancreatic duct epithelial cells. Channels (Austin) (2013) 0.83
Resonant microchannel volume and mass measurements show that suspended cells swell during mitosis. J Cell Biol (2015) 0.83
Altered expression of two-pore domain potassium (K2P) channels in cancer. PLoS One (2013) 0.82
Integrated analysis of drug-induced gene expression profiles predicts novel hERG inhibitors. PLoS One (2013) 0.82
Role of ion channels in regulating Ca²⁺ homeostasis during the interplay between immune and cancer cells. Cell Death Dis (2015) 0.81
Periodic expression of Kv10.1 driven by pRb/E2F1 contributes to G2/M progression of cancer and non-transformed cells. Cell Cycle (2016) 0.80
Calmodulin Regulates Human Ether à Go-Go 1 (hEAG1) Potassium Channels through Interactions of the Eag Domain with the Cyclic Nucleotide Binding Homology Domain. J Biol Chem (2016) 0.79
Inhibition of epidermal growth factor signaling by the cardiac glycoside ouabain in medulloblastoma. Cancer Med (2014) 0.78
Long-term channel block is required to inhibit cellular transformation by human ether-à-go-go-related gene (hERG1) potassium channels. Mol Pharmacol (2014) 0.77
Bioelectrical regulation of cell cycle and the planarian model system. Biochim Biophys Acta (2015) 0.77
Drug Repositioning for Cancer Therapy Based on Large-Scale Drug-Induced Transcriptional Signatures. PLoS One (2016) 0.76
Medulloblastoma: Pump up the volume. Nat Rev Cancer (2012) 0.75
Placing ion channels into a signaling network of T cells: from maturing thymocytes to healthy T lymphocytes or leukemic T lymphoblasts. Biomed Res Int (2015) 0.75
Profile of Lily and Yuh Nung Jan, winners of the 2017 Vilcek Prize in Biomedical Science. Proc Natl Acad Sci U S A (2017) 0.75
Knockdown of the small conductance Ca(2+) -activated K(+) channels is potently cytotoxic in breast cancer cell lines. Br J Pharmacol (2015) 0.75
Cell Cycle-dependent Changes in Localization and Phosphorylation of the Plasma Membrane Kv2.1 K+ Channel Impact Endoplasmic Reticulum Membrane Contact Sites in COS-1 Cells. J Biol Chem (2015) 0.75
Cullin 7 mediates proteasomal and lysosomal degradations of rat Eag1 potassium channels. Sci Rep (2017) 0.75
The DNA damage response: putting checkpoints in perspective. Nature (2000) 19.07
Altered neural cell fates and medulloblastoma in mouse patched mutants. Science (1997) 11.44
Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer (2009) 9.33
The genetic landscape of the childhood cancer medulloblastoma. Science (2010) 8.34
Medulloblastoma comprises four distinct molecular variants. J Clin Oncol (2010) 8.06
Control of neuronal precursor proliferation in the cerebellum by Sonic Hedgehog. Neuron (1999) 7.80
Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med (2009) 7.23
Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol (2011) 6.67
Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol (2006) 5.96
Subtypes of medulloblastoma have distinct developmental origins. Nature (2010) 5.94
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS One (2008) 5.86
Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science (2009) 5.40
Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells. Cancer Cell (2008) 5.06
Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma. Cancer Cell (2008) 4.68
Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat Genet (2009) 4.52
Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. J Clin Oncol (2010) 4.48
Nmyc upregulation by sonic hedgehog signaling promotes proliferation in developing cerebellar granule neuron precursors. Development (2003) 3.88
Sonic hedgehog promotes G(1) cyclin expression and sustained cell cycle progression in mammalian neuronal precursors. Mol Cell Biol (2000) 3.84
A distinct potassium channel polypeptide encoded by the Drosophila eag locus. Science (1991) 3.26
A novel somatic mouse model to survey tumorigenic potential applied to the Hedgehog pathway. Cancer Res (2006) 3.06
Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma. Sci Transl Med (2010) 2.86
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. Acta Neuropathol (2011) 2.82
Oncogenic potential of EAG K(+) channels. EMBO J (1999) 2.74
The behavior of four neurological mutants of Drosophila. Genetics (1969) 2.63
Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYC. Cancer Cell (2012) 2.45
Development of mice expressing a single D-type cyclin. Genes Dev (2002) 2.43
Transient inhibition of the Hedgehog pathway in young mice causes permanent defects in bone structure. Cancer Cell (2008) 2.42
Potassium channels, proliferation and G1 progression. J Membr Biol (1996) 2.16
A mouse model of the most aggressive subgroup of human medulloblastoma. Cancer Cell (2012) 2.15
The pathways to tumor suppression via route p38. Trends Biochem Sci (2007) 2.15
An animal model of MYC-driven medulloblastoma. Cancer Cell (2012) 2.12
Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct. Acta Neuropathol (2011) 2.01
Voltage-gated potassium channels in cell proliferation. Physiology (Bethesda) (2004) 1.89
A novel inward-rectifying K+ current with a cell-cycle dependence governs the resting potential of mammalian neuroblastoma cells. J Physiol (1995) 1.88
The Smo/Smo model: hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spread. Cancer Res (2008) 1.84
Pleiotropic role for MYCN in medulloblastoma. Genes Dev (2010) 1.84
Pyridinylimidazole compound SB 203580 inhibits the activity but not the activation of p38 mitogen-activated protein kinase. Biochem Biophys Res Commun (1999) 1.80
Overexpression of Eag1 potassium channels in clinical tumours. Mol Cancer (2006) 1.78
Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene. Cancer Cell (2003) 1.76
Ion channels and the hallmarks of cancer. Trends Mol Med (2010) 1.60
Role of voltage-gated potassium channels in cancer. J Membr Biol (2005) 1.60
Nodule formation and desmoplasia in medulloblastomas-defining the nodular/desmoplastic variant and its biological behavior. Brain Pathol (2007) 1.59
Cloning and characterization of glioma BK, a novel BK channel isoform highly expressed in human glioma cells. J Neurosci (2002) 1.56
A voltage-driven switch for ion-independent signaling by ether-à-go-go K+ channels. Proc Natl Acad Sci U S A (2006) 1.53
HERG potassium channels are constitutively expressed in primary human acute myeloid leukemias and regulate cell proliferation of normal and leukemic hemopoietic progenitors. Leukemia (2002) 1.47
Ion channels: functional expression and therapeutic potential in cancer. Colloquium on Ion Channels and Cancer. EMBO Rep (2008) 1.46
Silencing the activity and proliferative properties of the human EagI Potassium Channel by RNA Interference. J Biol Chem (2006) 1.43
Ether à go-go potassium channel expression in soft tissue sarcoma patients. Mol Cancer (2006) 1.42
Eag1 expression interferes with hypoxia homeostasis and induces angiogenesis in tumors. J Biol Chem (2008) 1.41
PBK/TOPK promotes tumour cell proliferation through p38 MAPK activity and regulation of the DNA damage response. Oncogene (2006) 1.40
Cell cycle-dependent expression of HERG1 and HERG1B isoforms in tumor cells. J Biol Chem (2002) 1.38
Targeting medulloblastoma: small-molecule inhibitors of the Sonic Hedgehog pathway as potential cancer therapeutics. Cancer Res (2005) 1.35
Sunitinib induces apoptosis and growth arrest of medulloblastoma tumor cells by inhibiting STAT3 and AKT signaling pathways. Mol Cancer Res (2010) 1.35
Cytoplasmic volume condensation is an integral part of mitosis. Cell Cycle (2007) 1.33
Characterization of an eag-like potassium channel in human neuroblastoma cells. J Physiol (1998) 1.33
ClC3 is a critical regulator of the cell cycle in normal and malignant glial cells. J Neurosci (2008) 1.30
KCNMA1 gene amplification promotes tumor cell proliferation in human prostate cancer. Oncogene (2006) 1.29
Novel roles for hERG K(+) channels in cell proliferation and apoptosis. Cell Death Dis (2011) 1.28
Mammalian cells change volume during mitosis. PLoS One (2008) 1.28
Inhibition of human ether à go-go potassium channels by Ca(2+)/calmodulin. EMBO J (2000) 1.27
The eag family of K+ channels in Drosophila and mammals. Ann N Y Acad Sci (1999) 1.17
Cell cycle-related changes in the conducting properties of r-eag K+ channels. J Cell Biol (1998) 1.15
Cloning and functional expression of rat eag2, a new member of the ether-à-go-go family of potassium channels and comparison of its distribution with that of eag1. Mol Cell Neurosci (2000) 1.12
Expression of the neurogenic basic helix-loop-helix transcription factor NEUROG1 identifies a subgroup of medulloblastomas not expressing ATOH1. Neuro Oncol (2007) 1.10
Overexpression of the G-protein inwardly rectifying potassium channel 1 (GIRK1) in primary breast carcinomas correlates with axillary lymph node metastasis. Cancer Res (2001) 1.10
Regulation of an ERG K+ current by Src tyrosine kinase. J Biol Chem (2002) 1.09
Hypotonic shock mediation by p38 MAPK, JNK, PKC, FAK, OSR1 and SPAK in osmosensing chloride secreting cells of killifish opercular epithelium. J Exp Biol (2005) 1.08
Inhibition of human ether à go-go potassium channels by Ca2+/calmodulin binding to the cytosolic N- and C-termini. FEBS J (2006) 1.06
Expression of MATH1, a marker of cerebellar granule cell progenitors, identifies different medulloblastoma sub-types. Neurosci Lett (2004) 1.05
Serum starvation induces H2AX phosphorylation to regulate apoptosis via p38 MAPK pathway. FEBS Lett (2008) 1.01
Activation of Akt and Erk pathways in medulloblastoma. Folia Neuropathol (2006) 0.98
Kinase activation of ClC-3 accelerates cytoplasmic condensation during mitotic cell rounding. Am J Physiol Cell Physiol (2011) 0.92
Altered expression of KCNK9 in colorectal cancers. APMIS (2004) 0.90
M phase-specific expression and phosphorylation-dependent ubiquitination of the ClC-2 channel. J Biol Chem (2002) 0.86
Calmodulin interaction with hEAG1 visualized by FRET microscopy. PLoS One (2010) 0.86
Knockdown of secreted protein acidic and rich in cysteine (SPARC) expression diminishes radiosensitivity of glioma cells. Cancer Biother Radiopharm (2011) 0.81
Predominant expression of Kv1.3 voltage-gated K+ channel subunit in rat prostate cancer cell lines: electrophysiological, pharmacological and molecular characterisation. Pflugers Arch (2003) 0.80
An essential role for p38 MAPK in cerebellar granule neuron precursor proliferation. Acta Neuropathol (2012) 0.79
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell (2010) 39.09
Signatures of mutational processes in human cancer. Nature (2013) 21.63
International network of cancer genome projects. Nature (2010) 20.35
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling. Cell (2006) 10.06
Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature (2010) 9.81
Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev (2002) 8.56
The genetic landscape of the childhood cancer medulloblastoma. Science (2010) 8.34
Medulloblastoma comprises four distinct molecular variants. J Clin Oncol (2010) 8.06
Expression cloning of TMEM16A as a calcium-activated chloride channel subunit. Cell (2008) 7.79
Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma. Nat Med (2006) 7.10
Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell (2012) 6.71
Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol (2011) 6.67
Medulloblastoma growth inhibition by hedgehog pathway blockade. Science (2002) 6.53
A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma. Cancer Cell (2006) 6.15
Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell (2012) 6.07
Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol (2006) 5.96
miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med (2008) 5.91
Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell (2002) 5.64
Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res (2011) 5.40
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature (2012) 5.23
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet (2009) 5.13
Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell (2002) 5.11
Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells. Cancer Cell (2008) 5.06
Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science (2011) 5.04
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. N Engl J Med (2015) 5.03
Hippocampal neuronal polarity specified by spatially localized mPar3/mPar6 and PI 3-kinase activity. Cell (2003) 4.84
Comparing genomic expression patterns across species identifies shared transcriptional profile in aging. Nat Genet (2004) 4.77
Dissecting the genomic complexity underlying medulloblastoma. Nature (2012) 4.77
Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma. Cancer Cell (2008) 4.68
Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib. J Natl Cancer Inst (2005) 4.63
Tiling of the Drosophila epidermis by multidendritic sensory neurons. Development (2002) 4.59
Mouse brain organization revealed through direct genome-scale TF expression analysis. Science (2004) 4.55
Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat Genet (2009) 4.52
Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma. Neuron (2007) 4.47
Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature (2012) 4.13
Corridors of migrating neurons in the human brain and their decline during infancy. Nature (2011) 4.12
Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme. Neuro Oncol (2005) 4.10
Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer (2008) 3.98
The hypoxic response of tumors is dependent on their microenvironment. Cancer Cell (2003) 3.89
Nmyc upregulation by sonic hedgehog signaling promotes proliferation in developing cerebellar granule neuron precursors. Development (2003) 3.88
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol (2012) 3.88
PIK3CA gene mutations in pediatric and adult glioblastoma multiforme. Mol Cancer Res (2006) 3.72
Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature (2010) 3.70
Shh and Gli3 are dispensable for limb skeleton formation but regulate digit number and identity. Nature (2002) 3.47
Akt and autophagy cooperate to promote survival of drug-resistant glioma. Sci Signal (2010) 3.35
A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell (2010) 3.34
Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet (2009) 3.33
FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma. J Clin Oncol (2011) 3.33
Branching out: mechanisms of dendritic arborization. Nat Rev Neurosci (2010) 3.26
Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin. J Clin Oncol (2011) 3.23
bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS. Science (2004) 3.20
Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response. Clin Cancer Res (2006) 3.15
Light-avoidance-mediating photoreceptors tile the Drosophila larval body wall. Nature (2010) 3.13
Control of dendritic branching and tiling by the Tricornered-kinase/Furry signaling pathway in Drosophila sensory neurons. Cell (2004) 3.13
Numb and Numbl are required for maintenance of cadherin-based adhesion and polarity of neural progenitors. Nat Neurosci (2007) 3.13
Targeting MYCN in neuroblastoma by BET bromodomain inhibition. Cancer Discov (2013) 3.11
Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. Cancer Cell (2011) 3.11
Drosophila sensory neurons require Dscam for dendritic self-avoidance and proper dendritic field organization. Neuron (2007) 3.08
Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma. J Clin Oncol (2007) 3.07
Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR. Genes Chromosomes Cancer (2004) 3.05
The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Cancer Res (2009) 3.03
Medulloblastomics: the end of the beginning. Nat Rev Cancer (2012) 3.01
Clonal selection drives genetic divergence of metastatic medulloblastoma. Nature (2012) 2.96
Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev (2009) 2.96
Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Res (2006) 2.95
Follicular lymphoma in the United States: first report of the national LymphoCare study. J Clin Oncol (2009) 2.95
Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol (2008) 2.92
Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel. Mol Cancer Ther (2007) 2.89
Local generation of glia is a major astrocyte source in postnatal cortex. Nature (2012) 2.87
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression. Genes Dev (2013) 2.86
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis. Lancet Oncol (2013) 2.82
Dendrites of distinct classes of Drosophila sensory neurons show different capacities for homotypic repulsion. Curr Biol (2003) 2.81
Different levels of the homeodomain protein cut regulate distinct dendrite branching patterns of Drosophila multidendritic neurons. Cell (2003) 2.80
Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity. Aging Cell (2009) 2.79
The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation. Cell (2013) 2.74
Progenitor cell maintenance requires numb and numblike during mouse neurogenesis. Nature (2002) 2.74
Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma. J Clin Oncol (2008) 2.71
Glioma stem cells: a midterm exam. Neuron (2008) 2.69